Caner Saygin

I am a physician scientist focusing on treating patients with leukemia, and studying leukemia biology and novel experimental therapeutics in research laboratory. After my medical school training, I did 2-years of postdoctoral fellowship at the Cleveland Clinic, and studied cancer stem cell biology in the laboratories of Drs. Justin Lathia and Ofer Reizes. During my internal medicine residency at The Ohio State University, I was mentored by Dr. John Byrd and focused my translational research on understanding genetics of acute myeloid leukemia stem cells, and new treatment approaches to target these disease-initiating cell populations. As a hematology/oncology fellow at the University of Chicago, I have the pleasure to work with Dr. Wendy Stock to develop promising new drugs for the management of acute leukemias. My current research focuses on the patterns of response and mechanisms of resistance to BH3 mimetics in ALL. My long-term career goal is to run a translational leukemia research laboratory and treat patients with leukemia.